Skip to main content

Month: March 2025

Toll Brothers Announces Opening of Camas Meadows Crossing in Camas, Washington

CAMAS, Wash., March 26, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, is pleased to announce its newest Portland-area community, Camas Meadows Crossing, is now open for sale in Camas, Washington. This is the first Toll Brothers luxury townhome community in the region, offering an array of personalization options at the Toll Brothers Design Studio. The Sales Center is now open at 3839 NW 65th Ave. in Camas.  Camas Meadows Crossing seamlessly blends elegance and comfort, featuring expertly crafted three-story townhome floor plans ranging up to 2,475+ square feet with 3 to 5 bedrooms and attached 2-car side-by-side garages. Homes within Camas Meadows Crossing are priced from the upper $600,000s.  Toll Brothers customers will experience one-stop shopping at the Toll Brothers Design...

Continue reading

Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast

WARREN, N.J., March 26, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug discovery, is pleased to share that Founder and CEO, Ryan Saadi, MD, MPH, has been named to the 2025 Health Care Power List by NJBIZ. This recognition highlights Dr. Saadi’s leadership and commitment to advancing healthcare innovation and accessibility in New Jersey and beyond. This announcement coincides with a significant milestone in Tevogen’s growth, the appointment of David E. Banko, as Global Head of Government Affairs and Patient Access. Mr. Banko’s focus will include advancing patient access, engaging with public and private payers, and securing coding, coverage, and reimbursement pathways, all essential to...

Continue reading

URW announces the successful placement of €815 Mn of new hybrid notes

Paris, March 26, 2025 Press release URW announces the successful placement of €815 Mn of new hybrid notes Unibail-Rodamco-Westfield (“URW” or “the Group”) announces the successful placement of new €815 Mn Deeply Subordinated Perpetual Fixed Rate Resettable Perp-NC 5.5 hybrid notes (Perp-NC 5.5 Hybrid Notes), at a coupon of 4.875%. This successful issuance received strong demand from investors. It was 3.1 times oversubscribed and had an order book of c. €2.5 Bn at its peak, reflecting investors’ appetite for URW’s credit. As announced earlier today, the Group has also launched a concurrent tender offer on its €995 Mn 7.250% Hybrid Perp-NC 2028 notes (“NC2028 Notes” – as Priority 1) and €750 Mn 2.875% Hybrid Perp-NC 2026 notes (as Priority 2, at the Group’s sole discretion). The tender offer will expire on April 2, 2025. The new notes are...

Continue reading

Valeo Shareholders’ Meeting 2025

PRESS RELEASE Valeo Shareholders’ Meeting 2025 Paris, March 26, 2025 – Valeo hereby informs its shareholders that its Combined (ordinary and extraordinary) Shareholders’ Meeting will be held at 2:30 pm on May 22, 2025 at 3 Mazarium, 3 Rue Mazarine, 75006 Paris. During this Shareholders’ Meeting, shareholders will be asked, in particular, to approve Valeo’s financial statements as well as the Group’s consolidated financial statements for the financial year ended December 31, 2024, to allocate the earnings for this financial year and to pay a dividend of 0.42 euro per share entitled to a dividend. If this dividend is approved, the ex-dividend date will be May 26, 2025, with a record date set at May 27, 2025, and the payment date will be May 28, 2025. The Board of Directors also decided to propose to the...

Continue reading

The Vita Coco Company Issues Statement Regarding NINGI Research Report

Reaffirms Fiscal Year 2025 Outlook and Long-Term Growth Algorithm NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today provided the following response to the recent short seller report issued by NINGI Research, who subsequently disclosed a short position in The Vita Coco Company stock. After reviewing the claims outlined in NINGI Research’s report, the Company has found that the report contains numerous inaccuracies and mischaracterizations. Contrary to this report, the Company has consistently and transparently addressed the matters discussed in the report through appropriate public disclosures. The Company stated on the Fourth Quarter and Fiscal-Year 2024 Earnings Call held on Wednesday, February...

Continue reading

R&M Trucking Takes Delivery of First Volvo VNR Electric Truck as First Volvo on Demand Customer

R&M Volvo VNR Electric TruckR&M Trucking has deployed the first Volvo VNR Electric truck as part of the Volvo on Demand Truck-as-a-Service initiative from Volvo Trucks North America and Volvo Financial Services.Greensboro, N.C., March 26, 2025 (GLOBE NEWSWIRE) — Volvo on Demand is a highly flexible, Truck-as-a-Service subscription initiative, designed to drive the adoption of zero-tailpipe emission technology by removing large upfront capital investments. Now, the very first Volvo on Demand customer in the U.S., R&M Trucking has started their subscription with a Volvo VNR Electric truck – carrying out local and regional deliveries at O’Hare International Airport in Chicago. Volvo on Demand is an innovative and highly customizable Truck-as-a-Service initiative from Volvo Trucks North America and Volvo Financial...

Continue reading

Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value

BOSTON, March 26, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today issued the following statement: The Atea Board of Directors and management team have recently taken several decisive actions to enhance shareholder value, including:Launching a comprehensive review of strategic opportunities – In the fourth quarter of 2024, Atea engaged an independent global investment bank to assist the Company in identifying potential opportunities to enhance shareholder value, including the exploration of strategic partnerships related to Atea’s Phase 3 program for the treatment of HCV. Taking substantial action to reduce costs – During the first quarter of 2025,...

Continue reading

Dassault Systèmes: filing of the English version of the 2024 Universal Registration Document

Press ReleaseVELIZY-VILLACOUBLAY, France — March 26, 2025 Publication of the English version of the 2024 Universal Registration Document Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces that the English version of its 2024 Universal Registration Document (constituting the Annual Financial Report) is now available on Dassault Systèmes’ website at https://investor.3ds.com/ (sections Regulated information or Events & Publications/Reports). Hard copies of the 2024 Universal Registration Document in English are also available upon request at Dassault Systèmes’ headquarters (10, rue Marcel Dassault, CS 40501 – 78946 Vélizy-Villacoublay, France). ### ABOUT DASSAULT SYSTÈMES Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients...

Continue reading

HighCo: 2024 annual earnings

Aix-en-Provence, 26 March 2025 (6 p.m.) HIGHCO: MANAGED DECLINE IN BUSINESS AND RESULTS IN 2024; PROPOSED DIVIDEND OF €0.25 PER SHARE; SALE OF HIGH CONNEXION Business decline less steep than expected in 20242024 gross profit of €69.16 m, down 7%. Sustained annual growth in the Activation division (up 7%), decline in Mobile businesses (down 4.3%) and a sharp decrease in Consulting & In-store media selling (down 28.8%). Decline in businesses in France (down 6.9%) and in International business (down 7.5%).Decline in results and profitability as anticipatedHeadline PBIT1 of €11.55 m, down 29.6%. Operating margin1 of 16.7%, down 540 basis points. Adjusted attributable net income2 of €7.28 m, down 33.2%. Adjusted earnings per share (EPS)2 of €0.37, down 32.3%.Financial position remains strongOperating cash flow of €12.3 m (excluding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.